CONGO - Israeli HIV Drug Successfully Fights Coronavirus

Arno Froese

Medical researchers in the Republic of the Congo have discovered that an Israeli-developed HIV drug apparently can be used to successfully treat critically ill COVID-19 patients. Furthermore, the drug might be available within “weeks to months, but not more” after further clinical trials are carried out.

Developed by the Israel-based company Zion Medical and the Hebrew University of Jerusalem, Gammora was recently approved for use in the central African country. 

“We were surprised because we wanted to see if [Gammora] would work, but we didn’t know that it would happen like this, and we saw improvement in terms of symptoms of COVID-19 within 48 hours,” Dr. Eynat Finkelshtein, chief scientific officer of Zion Medical, told The Media Line.

A small clinical trial began in Brazzaville on April 8. Conducted under “compassionate use” protocols, which enable seriously ill patients to access new or untested treatments, it was overseen by Clinique La Source’s Dr. Sebastian Mafoundzi alongside Dr. Roger Alphonse Bouity. World Health Organization (WHO) representative Albert Kazadi was called in as a private consultant to supervise.

The trial saw 30 critically ill patients in intensive care—some with HIV, others HIV-free—divided into two groups.

The first group of 15 patients (Group A) received standard-care treatment for HIV and coronavirus, namely antibiotics and the HIV medicine Atripla. The second group (Group B) received the antibiotics, Atripla and Gammora via injection over a period of nine days.

After two days, all 15 patients in Group B showed marked improvement in their COVID-19 symptoms.

“Of the 15 that got Gammora on top of standard care, four of them tested negative [for the virus] after nine days of treatment, and 11 were discharged from the ICU and transferred to the [hospital’s] internal medicine ward” for a full recovery, Finkelshtein said. 

As for the 15 members of Group A, 14 died during the same timeframe, and one remains in critical condition.

-www.jpost.com, 7 May 2020

Arno's commentary

Israel’s inventiveness is obviously second to none. They are involved in all kinds of projects virtually around the globe.

Here we are reminded of the promise given in Exodus 15:26: “And said, If thou wilt diligently hearken to the voice of the Lord thy God, and wilt do that which is right in his sight, and wilt give ear to his commandments, and keep all his statutes, I will put none of these diseases upon thee, which I have brought upon the Egyptians: for I am the Lord that healeth thee.” The last book in the Old Testament reads: “But unto you that fear my name shall the Sun of righteousness arise with healing in his wings; and ye shall go forth, and grow up as calves of the stall” (Malachi 4:2).

Arno Froese is the executive director of Midnight Call Ministries and editor-in-chief of the acclaimed prophetic magazines Midnight Call and News From Israel. He has authored a number of well-received books, and has sponsored many prophecy conferences in the U.S., Canada, and Israel. His extensive travels have contributed to his keen insight into Bible prophecy, as he sees it from an international perspective.

Read more from this author

ContactAbout UsPrivacy and Safety